# Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management

> **NCT03001453** · PHASE2 · COMPLETED · sponsor: **American Hip Institute** · enrollment: 107 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Liposomal Bupivacaine
- **DRUG:** 0.25% Bupivacaine with epinephrine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03001453
- **Lead sponsor:** American Hip Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03001453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03001453, "Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03001453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*